INMD — InMode Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1742692 ·
Last close
$13.81
Market Cap
$839.77M
52W High
$14.84
52W Low
$12.72
ADV30
885,127
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 82,017,000 | 61,552,000 | 10,056,000 | 11,562,000 | 750,837,000 | 394,295,000 | 89,584,000 |
| Dec 2025 | 103,854,000 | 81,300,000 | 25,991,000 | 27,025,000 | 766,429,000 | 302,543,000 | 83,231,000 |
| Sep 2025 | 93,165,000 | 72,309,000 | 20,897,000 | 21,863,000 | 734,605,000 | 252,437,000 | 81,220,000 |
| Jun 2025 | 95,602,000 | 76,450,000 | 22,881,000 | 26,742,000 | 708,348,000 | 216,237,000 | 79,911,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$86,599,000
Investing CF
$219,650,000
Financing CF
$-59,019,000
CapEx
$-1,059,000
Dividends Paid
—
Buybacks
$-58,725,000
EPS Diluted TTM
$1.36
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$968,532,000
Inventory
$71,408,000
Receivables
$72,212,000
ST Investments
$142,864,000
EBIT TTM
$79,825,000
Pretax Income TTM
$102,205,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$374,638,016
EBITDA
$80,521,000
Free Cash Flow
$43,626,624
Enterprise Value
$338,799,744
Total Cash
$537,158,976
Total Debt
$4,829,000
Shares Out
60,808,750
Trailing EPS
$1.35
Book Value
$10.78
ROE
13.6%
ROA
6.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 370,495,000 | 85,387,000 | 93,831,000 | 766,429,000 | 83,231,000 | — | 85,257,000 |
| Dec 2024 | 394,818,000 | 112,531,000 | 181,275,000 | 785,667,000 | 81,854,000 | — | 132,664,000 |
| Dec 2023 | 492,048,000 | 195,660,000 | 197,919,000 | 863,286,000 | 75,914,000 | — | 176,826,000 |
| Dec 2022 | 454,271,000 | 197,854,000 | 161,520,000 | 644,409,000 | 89,791,000 | — | 181,578,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.48
Max Pain — expiry 2026-08-21
max pain strike: $17.00 · spot: $13.81 · call oi: 2,655 · put oi: 3,847
Expected Move to 2026-08-21:
±$1.95
(14.12%) —
implied range
$11.86 –
$15.76
· ATM straddle on $14.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVR | Anteris Technologies Global Corp. | $883.87M | $9.08 | — |
| STVN | Stevanato Group S.p.A. | $893.28M | $17.97 | — |
| DRTS | Alpha Tau Medical Ltd. | $936.68M | $10.37 | — |
| SSII | SS Innovations International, Inc. | $746.49M | $3.73 | — |
| CBLL | Ceribell, Inc. | $713.32M | $18.80 | — |
News headlines (Yahoo Finance, 1h cache)
Doma Perpetual Buys Another $5.6 Million of Nomad Foods With the Stock Down 20% in 2026
2026-05-21 15:37 · Yahoo
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
2026-05-20 11:00 · Yahoo
Undervalued Small Caps With Insider Buying To Watch In May 2026
2026-05-14 11:39 · Yahoo
InMode to Present at Upcoming Investor Conferences and Events
2026-05-13 12:30 · Yahoo
InMode Ltd. Q1 2026 Earnings Call Summary
2026-05-06 20:52 · Yahoo
InMode (INMD) Q1 2026 Earnings Call Transcript
2026-05-06 20:03 · Yahoo
InMode Q1 Earnings Call Highlights
2026-05-06 18:34 · Yahoo
InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase
2026-05-06 11:00 · Yahoo
Assessing InMode (INMD) Valuation After Reaffirmed 2026 Revenue Guidance
2026-04-27 07:04 · Yahoo
3 Undervalued Small Caps With Insider Buying Across Regions
2026-04-14 11:39 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.